EARNINGS Dar Global profit multiplies, Hemogenyx loss widens - Marketscreener.com
HOPHF Stock | USD 1.24 0.00 0.00% |
Roughly 55% of Hemogenyx Pharmaceuticals' stockholders are presently thinking to get in. The analysis of overall sentiment of trading Hemogenyx Pharmaceuticals Plc pink sheet suggests that some investors are interested at this time. The current market sentiment, together with Hemogenyx Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Hemogenyx Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
Hemogenyx Pharmaceuticals pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Hemogenyx daily returns and investor perception about the current price of Hemogenyx Pharmaceuticals Plc as well as its diversification or hedging effects on your existing portfolios.
Hemogenyx |
EARNINGS Dar Global profit multiplies, Hemogenyx loss widens Marketscreener.com
Read at news.google.com
Hemogenyx Pharmaceuticals Fundamental Analysis
We analyze Hemogenyx Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hemogenyx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hemogenyx Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
Hemogenyx Pharmaceuticals is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Hemogenyx Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Hemogenyx Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Hemogenyx Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Hemogenyx Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Hemogenyx Pharmaceuticals Related Equities
ELVN | Enliven Therapeutics | 1.22 | ||||
FENC | Fennec Pharmaceuticals | 0.33 | ||||
CCCC | C4 Therapeutics | 0.52 | ||||
FHTX | Foghorn Therapeutics | 0.85 | ||||
MNPR | Monopar Therapeutics | 2.78 | ||||
STTK | Shattuck Labs | 3.15 | ||||
INBX | Inhibrx | 3.42 | ||||
CELC | Celcuity LLC | 4.44 | ||||
PMN | ProMIS Neurosciences | 4.67 | ||||
GNLX | Genelux Common | 4.85 | ||||
PRLD | Prelude Therapeutics | 5.79 | ||||
QNRX | Quoin Pharmaceuticals | 6.06 | ||||
CVKD | Cadrenal Therapeutics, | 7.23 | ||||
GLUE | Monte Rosa | 8.27 | ||||
CING | Cingulate | 8.30 | ||||
DYAI | Dyadic International | 10.82 | ||||
SNTI | Senti Biosciences | 11.96 |
Complementary Tools for Hemogenyx Pink Sheet analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
CEOs Directory Screen CEOs from public companies around the world | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |